Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy

Background: Serum carbohydrate antigen 19-9 (CA 19-9) has been shown to be a sensitive and specific serum marker for pancreatic cancer. Little has been published about correlations between baseline CA 19-9 level or changes to CA 19-9 level and median overall survival (mOS). Its impact on monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelzer, Uwe, Hilbig, Andreas, Sinn, Marianne, Stieler, Jens, Bahra, Marcus, Dörken, Bernd, Riess, Hanno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682131/
https://www.ncbi.nlm.nih.gov/pubmed/23785668
http://dx.doi.org/10.3389/fonc.2013.00155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682131/
https://www.ncbi.nlm.nih.gov/pubmed/23785668
http://dx.doi.org/10.3389/fonc.2013.00155

Ejemplares similares